Log In
BCIQ
Print this Print this
 

myT Primer KRAS assay

  Manage Alerts
Collapse Summary General Information
Company Swift Biosciences Inc.
DescriptionAssay using myT Primer qPCR technology to detect K-Ras mutations
Molecular Target K-Ras (KRAS)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationCancer, Diagnostic
Indication DetailsDetect K-Ras mutations
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today